BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34628872)

  • 21. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang X; Li M; Meng X; Kong L; Zhang Y; Wei G; Zhang X; Shi F; Hu M; Zhang G; Yu J
    Radiat Oncol; 2014 Feb; 9():64. PubMed ID: 24571804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis.
    Cheng YJ; Jing SW; Zhu LL; Wang J; Wang L; Liu Q; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ
    J Radiat Res; 2018 Sep; 59(5):604-615. PubMed ID: 30085197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
    Chen X; Zhang Y; Zhou X; Wang M; Na F; Zhou L; Xu Y; Zou B; Xue J; Liu Y; Gong Y
    Front Oncol; 2023; 13():1274924. PubMed ID: 37886166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
    Yang M; Zhang H; Huo X; Chen C; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of log odds of positive lymph nodes for locoregional recurrence in oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Drebber U; Zöller J; Kreppel M
    Oral Oncol; 2017 Sep; 72():48-55. PubMed ID: 28797461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of number of dissected lymph nodes on survival in patients with thoracic esophageal squamous cell carcinoma after radical resection].
    Wang YX; Wang LL; Yang Q; He M; Qi Z; Qiao XY; Zhu SC
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):150-5. PubMed ID: 26899337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.
    Kawamoto T; Nihei K; Sasai K; Karasawa K
    Esophagus; 2018 Oct; 15(4):256-262. PubMed ID: 30225742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic analysis of cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma].
    Chen J; Zhu K; Zheng X; Chen M; Lin Y; Pan C; Pan J
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):612-6. PubMed ID: 25430029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
    Wang Y; Zhu L; Xia W; Wu L; Wang F
    World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.
    Onozawa M; Nihei K; Ishikura S; Minashi K; Yano T; Muto M; Ohtsu A; Ogino T
    Radiother Oncol; 2009 Aug; 92(2):266-9. PubMed ID: 18952308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
    Jing Z; Chen T; Zhang X; Wu S
    Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
    Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.
    Jing W; Zhu H; Guo H; Zhang Y; Shi F; Han A; Li M; Kong L; Yu J
    PLoS One; 2015; 10(12):e0143007. PubMed ID: 26636574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma.
    Luo H; Cui YY; Zhang JG; Sun YN; Zheng XL; Yang CL; Ye K; Ge H
    Clin Transl Oncol; 2018 Jul; 20(7):889-898. PubMed ID: 29143229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.